A Phase 1 Study of NOV1601(CHC2014) in Adult Subjects With Solid Organ Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dong-Wan Kim, MD, PhD
Seoul National University Hospital
Principal Investigator - Sang-Joon Shin, MD, PhD
Severance Hospital
Principal Investigator - Tak Yun, MD, PhD
National Cancer Center
Principal Investigator - Yong-Wha Moon, MD, PhD
CHA Bundang Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- National Cancer Center
Goyang-si, Gyeonggi-do, South Korea
- Cha Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Aug 2019
- Primary completion
- 22 Jan 2021
- Completion
- 29 Jan 2021
- Last update posted
- 16 Sept 2021
- Registered enrollment
- 17
- Registry id
- NCT04014257
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.